Products for Research Use Only
RegisterLogin

Research Grade Solanezumab

CAT: 1220-DHC12505Size: 100 μgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1220-DHC12505Size:100 μg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the Aβ peptide. It recognizes soluble monomeric, not fibrillar, Aβ. Solanezumab (formerly known as LY2062430) is a monoclonal antibody being developed by Lilly as a potential therapy for people with mild cognitive impairment caused by Alzheimer’s disease.
Product Name Alternative
LY2062430, CAS: 955085-14-0
Accession Number
P05067
Expression System
Mammalian Cells
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH 7.4.
Notes
For research use only. Not suitable for clinical or therapeutic use.

Related Products

CatalogName
DHD17404Research Grade Tucotuzumab
DHD30405Research Grade Fianlimab
DHB95401Research Grade Emapalumab
DHG52001Research Grade Anetumab
DHC82406Research Grade Posdinemab
DHH02231Research Grade Rulonilimab
DHK07702Research Grade Forimtamig
DHJ92104Research Grade Izuralimab
DHJ70122Research Grade Davoceticept
DHA30606Research Grade Ramatercept

Alternative Products

CatalogName
MBS1563394-01Research Grade Solanezumab
ICH5871-20mgSolanezumab Biosimilar - Research Grade
10-314Solanezumab (APP Abeta, soluble monomer) - Research Grade Biosimilar
GTR18117020Solanezumab (APP Abeta, soluble monomer) - Research Grade Biosimilar Antibody
PX-TA1211-01Solanezumab Biosimilar - Anti-APP Abeta, soluble monomer mAb - Research Grade
GC0057Research Grade
HF943026-01Research Grade Gevokizumab
HY328026-01Research Grade Ziltivekimab
HY328046-01Research Grade Olokizumab
HB769026-01Research Grade Briakinumab

Popular Products